![Foto de Eduardo](/img/nophoto.png)
Eduardo
Agüera Morales
Publicaciones en las que colabora con Eduardo Agüera Morales (8)
2023
-
Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approach
Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 9, Núm. 2
2022
-
Delayed cognitive processing and treatment status quo bias in early-stage multiple sclerosis
Multiple Sclerosis and Related Disorders, Vol. 68
-
Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis
Neurology, Vol. 99, Núm. 17, pp. E1926-E1944
-
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
Multiple Sclerosis and Related Disorders, Vol. 63
-
Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosis
Multiple Sclerosis and Related Disorders, Vol. 64
-
Measuring productivity loss in early relapsing-remitting multiple sclerosis
Multiple Sclerosis and Related Disorders, Vol. 58
2021
-
Determinants of therapeutic lag in multiple sclerosis
Multiple Sclerosis Journal, Vol. 27, Núm. 12, pp. 1838-1851
2015
-
Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab
Annals of Neurology, Vol. 77, Núm. 3, pp. 447-457